Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puyu Shi

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
BMC Medical Genomics|December 4, 2021
Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLCMeng Li, Yanpeng Zhang, Meng Fan, et al.
Journal of Cancer|July 24, 2019
Association between Polymorphisms of Vitamin D Receptor and Lung Cancer Susceptibility: Evidence from an Updated Meta-analysisMeng Li, Xinyu Liu, Na Liu, et al.
Oncology Reports|April 28, 2021
EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cellsLei Gao, Tian Yang, Shuo Zhang, et al.
Cancer|June 5, 2020
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancersJiajia Gu, Weilong Yao, Puyu Shi, et al.
Translational Oncology|March 12, 2019
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR MutationsPuyu Shi, Shuo Zhang, Lei Zhu, et al.
Molecular Biology Reports|February 12, 2025
Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinomaMeng Fan, Meng Li, Jiejun Zhou, et al.
Frontiers in Oncology|February 17, 2022
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung AdenocarcinomaMeng Li, Hui Ren, Yanpeng Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsPuyu Shi, Hannah Chapman, Lisa Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Social cognition in mild cognitive impairment and dementia: A systematic review and meta-analysisPuyu Shi, Hannah Chapman, Lisa Liu, et al.
Clinical Proteomics|June 7, 2019
Stage-associated differences in the serum <i>N</i>- and <i>O</i>-glycan profiles of patients with non-small cell lung cancerYiqian Liang, Peng Han, Ting Wang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
BMC Medical Genomics|December 4, 2021
Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLCMeng Li, Yanpeng Zhang, Meng Fan, et al.
Journal of Cancer|July 24, 2019
Association between Polymorphisms of Vitamin D Receptor and Lung Cancer Susceptibility: Evidence from an Updated Meta-analysisMeng Li, Xinyu Liu, Na Liu, et al.
Oncology Reports|April 28, 2021
EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non‑small cell lung cancer cellsLei Gao, Tian Yang, Shuo Zhang, et al.
Cancer|June 5, 2020
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancersJiajia Gu, Weilong Yao, Puyu Shi, et al.
Translational Oncology|March 12, 2019
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR MutationsPuyu Shi, Shuo Zhang, Lei Zhu, et al.
Molecular Biology Reports|February 12, 2025
Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinomaMeng Fan, Meng Li, Jiejun Zhou, et al.
Frontiers in Oncology|February 17, 2022
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung AdenocarcinomaMeng Li, Hui Ren, Yanpeng Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsPuyu Shi, Hannah Chapman, Lisa Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Social cognition in mild cognitive impairment and dementia: A systematic review and meta-analysisPuyu Shi, Hannah Chapman, Lisa Liu, et al.
Clinical Proteomics|June 7, 2019
Stage-associated differences in the serum <i>N</i>- and <i>O</i>-glycan profiles of patients with non-small cell lung cancerYiqian Liang, Peng Han, Ting Wang, et al.
Pageof 4